Randomised placebo-controlled safety and tolerability trial of FK506 (tacrolimus) for pulmonary arterial hypertension
Conversion from tacrolimus‐mycophenolate mofetil to tacrolimus‐mTOR immunosuppression after kidney‐pancreas transplantation reduces the incidence of both BK and CMV viremia
Tags: allogeneic organ transplant, Astagraf XL®, FK506, fujimycin, immunosuppressant, interleukin-2 production inhibitor, macrolide calcineurin inhibitor, Prograf®, Protopic®
BASi Method Number SAP.1415
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
